Inhalant and Additional Mucosal-Related Environmental Risks for Rheumatoid Arthritis

Rheum Dis Clin North Am. 2022 Nov;48(4):781-798. doi: 10.1016/j.rdc.2022.06.002.

Abstract

Rheumatoid arthritis (RA) occurs as the result of a complex interplay of environmental factors in a genetically susceptible individual. There is considerable evidence that the lungs may serve as an initial site of tolerance loss in the generation of RA-related autoimmunity, and several environmental inhalant exposures and lung diseases have been associated with RA risk. There is additional evidence that immune and microbial dysregulation of other mucosal sites, including the oral and gastrointestinal mucosa, may contribute to the development of RA. Epidemiologic evidence linking mucosal exposures to various environmental insults as risk determinants in RA will be reviewed.

Keywords: Anticitrullinated protein antibodies; Autoantibodies; Autoimmunity; Mucosal inflammation; Rheumatoid arthritis.

Publication types

  • Review
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Arthritis, Rheumatoid* / epidemiology
  • Arthritis, Rheumatoid* / etiology
  • Autoantibodies
  • Autoimmunity
  • Humans
  • Immune Tolerance
  • Lung
  • Mucous Membrane

Substances

  • Autoantibodies